tert-butyl 2-(aminomethyl)-1-oxa-8-azaspiro[4.5]decane-8-carboxylate hydrochloride, 500mg

(R)-Octahydropyrrolo[1,2-a]pyrazine dihydrochloride, 95.0%, 1g

3,4-Dichloro-5-(chlorosulfonyl)benzoic acid, 95+%, 5g

tert-Butyl 3-hydroxypent-4-enoate, 95.0%, 5g

4-Quinazolinamine, N-(1-cyclohexyl-4-piperidinyl)-2-[hexahydro-4-(1-methylethyl)-1H-1,4-diazepin-1-yl]-6-methoxy-7-[3-(1-piperidinyl)propoxy]-, 98%, 5mg

2-Amino-4-cyanopyrimidine, 95.0%, 5g

ácido ortofosfórico al 40%, extra puro, 1 l, envase de plástico.

4-(Cyclopropylmethoxy)phenol, 98%, 100mg

Ethyl 5-methyl-3-(thiophen-2-yl)-1H-pyrrole-2-carboxylate, 97.0%, 100mg

tert-Butyl N-[1-(2-bromophenyl)cyclopropyl]carbamate, 100mg

4-Isopropylaminodiphenylamine>97.0%(HPLC)(T)500g

Boc-N-Methyl-Aminoisobutyric acid, 97%, 5g

4,5-Dibromo-1,2-phenylenediamine>98.0%(HPLC)(T)25g